Xukun Li

Shenzhen Key Laboratory Of Epigenetics And Precision Medicine For Cancers, Chinese Academic Of Medical Sciences And Peking Union Medical College
Shenzhen, 518116, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

NKX2-5/LHX1 and UHRF1 Establishing a Positive Feedback Regulatory Circuitry Drives Esophageal Squamous Cell Carcinoma through Epigenetic Dysregulation.

NKX2-5/LHX1 and UHRF1 Establishing a Positive Feedback Regulatory Circuitry Drives Esophageal Squamous Cell Carcinoma through Epigenetic Dysregulation.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 23, 2024

The transcriptional landscape and clinico-biological characterization of human endogenous retroviruses in esophageal squamous cell carcinoma.

The transcriptional landscape and clinico-biological characterization of human endogenous retroviruses in esophageal squamous cell carcinoma.

Journal: International journal of cancer

Published: May 12, 2024

LHX2 Enhances the Malignant Phenotype of Esophageal Squamous Cell Carcinoma by Upregulating the Expression of SERPINE2.

LHX2 Enhances the Malignant Phenotype of Esophageal Squamous Cell Carcinoma by Upregulating the Expression of SERPINE2.

Journal: Genes

Published: July 19, 2022

Disruption of enhancer-driven S100A14 expression promotes esophageal carcinogenesis.

Disruption of enhancer-driven S100A14 expression promotes esophageal carcinogenesis.

Journal: Cancer letters

Published: May 19, 2022

The oncogenomic function of androgen receptor in esophageal squamous cell carcinoma is directed by GATA3.

The oncogenomic function of androgen receptor in esophageal squamous cell carcinoma is directed by GATA3.

Journal: Cell research

Published: May 25, 2020

USP48 Sustains Chemoresistance and Metastasis in Ovarian Cancer.

USP48 Sustains Chemoresistance and Metastasis in Ovarian Cancer.

Journal: Current cancer drug targets

Published: December 02, 2019

A S100A14-CCL2/CXCL5 signaling axis drives breast cancer metastasis.

A S100A14-CCL2/CXCL5 signaling axis drives breast cancer metastasis.

Journal: Theranostics

Published: November 13, 2019

S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin.

S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin.

Journal: Journal of ovarian research

Published: August 14, 2019

USP39 promotes ovarian cancer malignant phenotypes and carboplatin chemoresistance.

USP39 promotes ovarian cancer malignant phenotypes and carboplatin chemoresistance.

Journal: International journal of oncology

Published: October 19, 2018

S100A1 promotes cell proliferation and migration and is associated with lymph node metastasis in ovarian cancer.

S100A1 promotes cell proliferation and migration and is associated with lymph node metastasis in ovarian cancer.

Journal: Discovery medicine

Published: June 09, 2017

MicroRNA-182 drives colonization and macroscopic metastasis via targeting its suppressor SNAI1 in breast cancer.

MicroRNA-182 drives colonization and macroscopic metastasis via targeting its suppressor SNAI1 in breast cancer.

Journal: Oncotarget

Published: June 15, 2016

MicroRNA-17/20a impedes migration and invasion via TGF-β/ITGB6 pathway in esophageal squamous cell carcinoma.

MicroRNA-17/20a impedes migration and invasion via TGF-β/ITGB6 pathway in esophageal squamous cell carcinoma.

Journal: American journal of cancer research

Published: June 12, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026